3551 - 3600 of 6431 Results
Title
Year
-
OPENTitle: Site-specific neuronal and motor effects of short-term intermittent burst deep brain stimulation in non-human primatesJournal Name: Brain StimulationPublisher: Elsevier BVVol: 18Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2025.05.009Best OA location URL: https://www.brainstimjrnl.com/action/showPdf?pii=S1935861X25001135Citation Count: 0
-
OPENTitle: Cerebral topography of vesicular cholinergic transporter changes in neurologically intact adults: A [18F]FEOBV PET studyJournal Name: Aging BrainPublisher: Elsevier BVVol: 2Issue #:Start Page: 100039End Page: 100039Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbas.2022.100039Best OA location URL: https://doi.org/10.1016/j.nbas.2022.100039Citation Count: 30
-
OPENTitle: Monitoring PARKIN RBR Ubiquitin Ligase Activation States with UbFluorJournal Name: Current Protocols in Chemical BiologyPublisher: WileyVol: 10Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cpch.45Citation Count: 6
-
OPENTitle: A functionalized hydroxydopamine quinone links thiol modification to neuronal cell deathJournal Name: Redox BiologyPublisher: Elsevier BVVol: 28Issue #:Start Page: 101377End Page: 101377Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.redox.2019.101377Best OA location URL: https://doi.org/10.1016/j.redox.2019.101377Citation Count: 27
-
OPENTitle: Basal Ganglia Pathways Associated With Therapeutic Pallidal Deep Brain Stimulation for Tourette SyndromeJournal Name: Biological Psychiatry: Cognitive Neuroscience and NeuroimagingPublisher: Elsevier BVVol: 6Issue #: 10Start Page: 961End Page: 972Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.bpsc.2020.11.005Best OA location URL: https://doi.org/10.1016/j.bpsc.2020.11.005Citation Count: 40
-
OPENTitle: Profiling migraine patients according to clinical and psychophysical characteristics: clinical validity of distinct migraine clustersJournal Name: Neurological SciencesPublisher: Springer Science and Business Media LLCVol: 45Issue #: 3Start Page: 1185End Page: 1200Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s10072-023-07118-8Best OA location URL: https://link.springer.com/content/pdf/10.1007/s10072-023-07118-8.pdfCitation Count: 5
-
OPENTitle: Pathogenetic Contributions and Therapeutic Implications of Transglutaminase 2 in Neurodegenerative DiseasesJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 25Issue #: 4Start Page: 2364End Page: 2364Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms25042364Best OA location URL: https://www.mdpi.com/1422-0067/25/4/2364/pdf?version=1708157539Citation Count: 3
-
OPENTitle: Alpha-synuclein abundance and localization are regulated by the RNA-binding protein PUMILIO1Journal Name: Cell ReportsPublisher: Elsevier BVVol: 44Issue #: 8Start Page: 116145End Page: 116145Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.celrep.2025.116145Best OA location URL: https://doi.org/10.1016/j.celrep.2025.116145Citation Count: 1
-
OPENTitle: Cerebral white matter rarefaction has both neurodegenerative and vascular causes and may primarily be a distal axonopathyJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 82Issue #: 6Start Page: 457End Page: 466Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/jnen/nlad026Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10209646/pdf/nlad026.pdfCitation Count: 13
-
OPENTitle: Low plasma serotonin linked to higher nigral iron in Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-03700-2Best OA location URL: https://www.nature.com/articles/s41598-021-03700-2.pdfCitation Count: 13
-
OPENTitle: Effects of prolonged selective serotonin reuptake inhibition on the development and expression of l-DOPA-induced dyskinesia in hemi-parkinsonian ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 77Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2013.09.017Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3865178Citation Count: 63
-
OPENTitle: Non-Motor Symptoms as Markers of Disease Severity in Parkinson’s Disease: Associations Between Constipation, Depression, REM Sleep Behavior Disorder, and Motor ImpairmentJournal Name: BiomedicinesPublisher: MDPI AGVol: 13Issue #: 11Start Page: 2704End Page: 2704Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3390/biomedicines13112704Best OA location URL: https://www.mdpi.com/2227-9059/13/11/2704/pdf?version=1762184201Citation Count: 0
-
OPENTitle: French validation of the questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease–Rating Scale (QUIP-RS)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 63Issue #:Start Page: 117End Page: 123Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.026Best OA location URL: http://www.prd-journal.com/article/S1353802019300720/pdfCitation Count: 12
-
OPENTitle: Initiating pharmacotherapy in early Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 8Start Page: 643End Page: 644Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30225-8Best OA location URL: https://pure.amc.nl/en/publications/initiating-pharmacotherapy-in-early-parkinsons-disease(38fe3866-cce3-4a08-934a-d979a3cec1cc).htmlCitation Count: 5
-
OPENTitle: Method comparison study of the Elecsys® β-Amyloid (1–42) CSF assay versus comparator assays and LC-MS/MSJournal Name: Clinical BiochemistryPublisher: Elsevier BVVol: 72Issue #:Start Page: 7End Page: 14Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.clinbiochem.2019.05.006Best OA location URL: https://doi.org/10.1016/j.clinbiochem.2019.05.006Citation Count: 34
-
OPENTitle: Novel method to ascertain chromatin accessibility at specific genomic loci from frozen brain homogenates and laser capture microdissected defined cellsJournal Name: NeuroepigeneticsPublisher: Elsevier BVVol: 6Issue #:Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nepig.2016.03.001Best OA location URL: https://doi.org/10.1016/j.nepig.2016.03.001Citation Count: 0
-
OPENTitle: Differential involvement of Ras‐GRF1 and Ras‐GRF2 in L‐DOPA‐induced dyskinesiaJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 2Issue #: 6Start Page: 662End Page: 678Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.202Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.202Citation Count: 20
-
OPENTitle: Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 42Issue #: 3Start Page: 327End Page: 340Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2011.01.024Best OA location URL: https://lup.lub.lu.se/record/1831976Citation Count: 169
-
OPENTitle: Investigating the ageing-Parkinson’s disease nexus: standardisation of in vitro models and techniques by the PD-AGE networkJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01137-2Best OA location URL: https://doi.org/10.1038/s41531-025-01137-2Citation Count: 0
- TOX3 Variants Are Involved in Restless Legs Syndrome and Parkinson’s Disease with Opposite Effects2018OPENTitle: TOX3 Variants Are Involved in Restless Legs Syndrome and Parkinson’s Disease with Opposite EffectsJournal Name: Journal of Molecular NeurosciencePublisher: Springer Science and Business Media LLCVol: 64Issue #: 3Start Page: 341End Page: 345Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s12031-018-1031-4Best OA location URL: https://zenodo.org/record/3911331Citation Count: 12
-
OPENTitle: Subthalamic neural entropy is a feature of freezing of gait in freely moving people with Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 108Issue #:Start Page: 288End Page: 297Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2017.09.002Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6386531Citation Count: 82
-
OPENTitle: Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson diseaseJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 2Issue #: 10Start Page: 949End Page: 959Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.246Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.246Citation Count: 172
- Atrophy and structural covariance of the cholinergic basal forebrain in primary progressive aphasia2016OPENTitle: Atrophy and structural covariance of the cholinergic basal forebrain in primary progressive aphasiaJournal Name: CortexPublisher: Elsevier BVVol: 83Issue #:Start Page: 124End Page: 135Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cortex.2016.07.004Best OA location URL: https://doi.org/10.1016/j.cortex.2016.07.004Citation Count: 20
-
OPENTitle: GBA mutations in Parkinson disease: earlier death but similar neuropathological featuresJournal Name: European Journal of NeurologyPublisher: WileyVol: 24Issue #: 11Start Page: 1363End Page: 1368Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ene.13395Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5657539Citation Count: 29
-
OPENTitle: The Sigma-2 Receptor/TMEM97, PGRMC1, and LDL Receptor Complex Are Responsible for the Cellular Uptake of Aβ42 and Its Protein AggregatesJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 57Issue #: 9Start Page: 3803End Page: 3813Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s12035-020-01988-1Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7415709Citation Count: 66
-
OPENTitle: Neurite Collapse and Altered ER Ca2+ Control in Human Parkinson Disease Patient iPSC-Derived Neurons with LRRK2 G2019S MutationJournal Name: Stem Cell ReportsPublisher: Elsevier BVVol: 12Issue #: 1Start Page: 29End Page: 41Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.stemcr.2018.11.021Best OA location URL: http://www.cell.com/article/S2213671118304909/pdfCitation Count: 72
-
OPENTitle: Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic EfficacyJournal Name: ACS Pharmacology & Translational SciencePublisher: American Chemical Society (ACS)Vol: 4Issue #: 4Start Page: 1306End Page: 1321Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsptsci.0c00162Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8369681Citation Count: 24
-
OPENTitle: The industrial solvent trichloroethylene induces LRRK2 kinase activity and dopaminergic neurodegeneration in a rat model of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 153Issue #:Start Page: 105312End Page: 105312Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105312Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105312Citation Count: 53
-
OPENTitle: Direct targeting of wild-type glucocerebrosidase by antipsychotic quetiapine improves pathogenic phenotypes in Parkinson’s disease modelsJournal Name: JCI InsightPublisher: American Society for Clinical InvestigationVol: 6Issue #: 19Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1172/jci.insight.148649Best OA location URL: http://insight.jci.org/articles/view/148649/files/pdfCitation Count: 7
-
OPENTitle: The polarity protein Par3 regulates APP trafficking and processing through the endocytic adaptor protein NumbJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 93Issue #:Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2016.03.022Best OA location URL: https://doaj.org/article/2fe6d6b60884479a958d8abe39fbefccCitation Count: 26
-
OPENTitle: Improved diagnosis of Parkinson's disease from a detailed olfactory phenotypeJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 4Issue #: 10Start Page: 714End Page: 721Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.447Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.447Citation Count: 15
-
OPENTitle: Doubly Constrained C-terminal of Roc (COR) Domain-Derived Peptides Inhibit Leucine-Rich Repeat Kinase 2 (LRRK2) DimerizationJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 14Issue #: 11Start Page: 1971End Page: 1980Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.3c00259Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.3c00259Citation Count: 17
-
OPENTitle: Understanding the role of genetic variability in LRRK2 in Indian populationJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 4Start Page: 496End Page: 505Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27558Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8985845Citation Count: 14
-
OPENTitle: Single-vesicle imaging quantifies calcium’s regulation of nanoscale vesicle clustering mediated by α-synucleinJournal Name: Microsystems & NanoengineeringPublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41378-020-0147-1Best OA location URL: https://www.nature.com/articles/s41378-020-0147-1.pdfCitation Count: 10
-
OPENTitle: Personality and reported quality of life in Parkinson's diseaseJournal Name: International Journal of Geriatric PsychiatryPublisher: WileyVol: 32Issue #: 3Start Page: 324End Page: 330Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/gps.4475Best OA location URL: http://doi.org/10.1002/gps.4475Citation Count: 24
-
OPENTitle: OnabotulinumtoxinA and cognitive behavioral therapy in functional dystonia: A pilot randomized clinical trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 63Issue #:Start Page: 174End Page: 178Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.009Best OA location URL: https://zenodo.org/record/3832127Citation Count: 17
-
OPENTitle: Methodological validation of Miro1 retention as a candidate Parkinson’s disease biomarkerJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01115-8Best OA location URL: https://www.nature.com/articles/s41531-025-01115-8.pdfCitation Count: 0
-
OPENTitle: Association between insomnia disorder and cognitive function in middle-aged and older adults: a cross-sectional analysis of the Canadian Longitudinal Study on AgingJournal Name: SleepPublisher: Oxford University Press (OUP)Vol: 42Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/sleep/zsz114Best OA location URL: https://academic.oup.com/sleep/article-pdf/42/8/zsz114/29106505/zsz114.pdfCitation Count: 62
-
OPENTitle: The experience of off periods: Qualitative analysis of interviews with persons with Parkinson's and carepartnersJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 1Issue #:Start Page: 31End Page: 36Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2019.07.008Best OA location URL: https://doi.org/10.1016/j.prdoa.2019.07.008Citation Count: 10
-
OPENTitle: Subtype definition of vascular parkinsonismJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 52Issue #:Start Page: 107End Page: 108Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.03.005Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6019183Citation Count: 1
-
OPENTitle: Synthesis and characterization of a series of chiral alkoxymethyl morpholine analogs as dopamine receptor 4 (D4R) antagonistsJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 26Issue #: 10Start Page: 2481End Page: 2488Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2016.03.102Best OA location URL: http://doi.org/10.1016/j.bmcl.2016.03.102Citation Count: 24
-
OPENTitle: Mapping movement, mood, motivation and mentation in the subthalamic nucleusJournal Name: Royal Society Open SciencePublisher: The Royal SocietyVol: 5Issue #: 7Start Page: 171177End Page: 171177Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1098/rsos.171177Best OA location URL: https://doi.org/10.1098/rsos.171177Citation Count: 34
-
OPENTitle: The Experience of OFF Periods in Parkinson’s Disease: Descriptions, Triggers, and Alleviating FactorsJournal Name: Journal of Patient-Centered Research and ReviewsPublisher: Aurora Health Care, Inc.Vol: 8Issue #: 3Start Page: 232End Page: 238Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.17294/2330-0698.1836Best OA location URL: https://institutionalrepository.aah.org/cgi/viewcontent.cgi?article=1836&context=jpcrrCitation Count: 13
-
OPENTitle: Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 PhosphorylationJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 157Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3791/58956-vBest OA location URL: https://discovery.dundee.ac.uk/files/39263103/58956_R4_RE.pdfCitation Count: 6
-
OPENTitle: Concurrent Validity of Zeno Instrumented Walkway and Video-Based Gait Features in Adults With Parkinson’s DiseaseJournal Name: IEEE Journal of Translational Engineering in Health and MedicinePublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 10Issue #:Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1109/jtehm.2022.3180231Best OA location URL: https://ieeexplore.ieee.org/ielx7/6221039/6563131/09787410.pdfCitation Count: 26
-
OPENTitle: Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: A potential mechanism leading to chronic inflammationJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 215Issue #: 1Start Page: 5End Page: 19Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2008.09.003Best OA location URL: http://doi.org/10.1016/j.expneurol.2008.09.003Citation Count: 240
-
OPENTitle: Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 10Start Page: 2329End Page: 2346Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.03.032Best OA location URL: http://doi.org/10.1016/j.neurobiolaging.2014.03.032Citation Count: 68
-
OPENTitle: SparkINFERNO: a scalable high-throughput pipeline for inferring molecular mechanisms of non-coding genetic variantsJournal Name: BioinformaticsPublisher: Oxford University Press (OUP)Vol: 36Issue #: 12Start Page: 3879End Page: 3881Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/bioinformatics/btaa246Best OA location URL: https://academic.oup.com/bioinformatics/article-pdf/36/12/3879/33437175/btaa246.pdfCitation Count: 13
-
OPENTitle: Aseptic, semi-sealed cranial chamber implants for chronic multi-channel neurochemical and electrophysiological neural recording in nonhuman primatesJournal Name: Journal of Neuroscience MethodsPublisher: Elsevier BVVol: 420Issue #:Start Page: 110467End Page: 110467Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jneumeth.2025.110467Best OA location URL: https://doi.org/10.1016/j.jneumeth.2025.110467Citation Count: 0
-
OPENTitle: FDG PET Parkinson’s disease-related pattern as a biomarker for clinical trials in early stage diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 20Issue #:Start Page: 572End Page: 579Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nicl.2018.08.006Best OA location URL: https://doi.org/10.1016/j.nicl.2018.08.006Citation Count: 83